Multivariable analysis of prognostic factors for EFS in infants with KMT2A-r ALL
| Variable . | No. of patients . | Hazard ratio . | SE (%) . | 95% CI (%) . | P . |
|---|---|---|---|---|---|
| Sex | |||||
| Male | 27 | 1 | — | — | |
| Female | 31 | 7.070 | 5.691 | 1.460-34.241 | .015 |
| Age at diagnosis, days | |||||
| 0-89 | 14 | 1 | — | — | |
| 90-179 | 28 | 1.674 | 1.120 | 0.451-6.211 | .441 |
| 180-365 | 16 | 0.129 | 0.160 | 0.011-1.469 | .099 |
| Prednisolone response | |||||
| PGR | 39 | 1 | — | 58.7-84.3 | |
| PPR | 19 | 1.214 | 0.584 | 31.3-69.3 | .687 |
| FCM-MRD at TP3 | |||||
| Negative | 49 | 1 | — | 55.8-78.5 | |
| Positive | 9 | 82.961 | 73.356 | 5.2-75.3 | <.001 |
| Variable . | No. of patients . | Hazard ratio . | SE (%) . | 95% CI (%) . | P . |
|---|---|---|---|---|---|
| Sex | |||||
| Male | 27 | 1 | — | — | |
| Female | 31 | 7.070 | 5.691 | 1.460-34.241 | .015 |
| Age at diagnosis, days | |||||
| 0-89 | 14 | 1 | — | — | |
| 90-179 | 28 | 1.674 | 1.120 | 0.451-6.211 | .441 |
| 180-365 | 16 | 0.129 | 0.160 | 0.011-1.469 | .099 |
| Prednisolone response | |||||
| PGR | 39 | 1 | — | 58.7-84.3 | |
| PPR | 19 | 1.214 | 0.584 | 31.3-69.3 | .687 |
| FCM-MRD at TP3 | |||||
| Negative | 49 | 1 | — | 55.8-78.5 | |
| Positive | 9 | 82.961 | 73.356 | 5.2-75.3 | <.001 |
CI, confidence interval.